Tumor Suppressor LncRNA on Chromosome 8p12 (TSLNC8): A Concise Review in Human Malignancies

Abstract

Tumor Suppressor Long Non-Coding RNA on Chromosome 8p12 (TSLNC8) is an RNA gene that generates a long non-coding RNA transcribed intergenically from both strands. Its significant role in human malignancies attracted significant attention in recent years. Expression analysis of TSLNC8 has been conducted in tissue specimens and cell lines using various techniques, including reverse transcription-quantitative polymerase chain reaction (RT-qPCR), in situ hybridization (ISH), and microarray analysis. Furthermore, functional studies involving the loss and/or gain of TSLNC8 function in cellular and animal models have been carried out. These investigations have highlighted the impact of TSLNC8 on key tumor-related processes, including migration, invasion, and metastasis. Moreover, TSLNC8 has emerged as a regulator capable of modulating critical signaling pathways, such as the Hippo, STAT3, WNT/β-catenin, and MAPK pathways. In this review, we comprehensively synthesize the findings derived from in vitro and in vivo studies, along with analyses conducted on clinical samples, to provide a comprehensive understanding of the multifaceted role of TSLNC8 as a promising tumor biomarker and a potential target for therapeutic interventions.

LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies

“…International Publisher [10][11][12][13][14]. LncRNAs have been found to be involved in a variety of biological processes, can act as oncogenes or tumor suppressors, and are associated with various aspects of cancer, including tumorigenesis, metastasis, and treatment resistance [15][16][17][18][19].…”

A concise review of the regulatory, diagnostic, and prognostic implications of HOXB-AS3 in tumors

“…They can be broadly categorized as sense, antisense, intronic, bidirectional, or intergenic, depending on their relationship with neighboring protein-coding genes 12 , 13 . In recent years, lncRNAs have gained increasing importance in cancer research, as considerable evidence 14 - 18 suggests their involvement in tumor initiation and progression by influencing various cellular processes, including cell cycle, survival, tumor invasion, and metastasis through multiple mechanisms at the transcriptional, post-transcriptional, or epigenetic levels. Importantly, lncRNAs have demonstrated promise as potential diagnostic and prognostic markers, as well as therapeutic targets in various types of cancer 19 - 22 .…”